Canntab Granted 2nd Patent For Immediate Release Cannabidiol Formulation Tablets
CA 3050150 to Canntab, related toits proprietary cannabidiol formulations with a priority date of January 23, 2017.
- CA 3050150 to Canntab, related toits proprietary cannabidiol formulations with a priority date of January 23, 2017.
- The Company now has patent protection in Canada and the USA providing an international scope to the Company's expanding portfolio of issued patents."
- Canntab has filed more than a dozen patent applications in the United States and Canada for which two have now been granted or allowed.
- On September 21, 2020 Canntab had announced that pursuant to a filing made inMarch 2017, the U.S. Patent and Trademark Office (USPTO) had issued U.S. Patent No.